-The Telegraph Calcutta: Private companies will be able to buy farm produce directly from farmers in Bengal. But the widely-anticipated whoop of exultation from Indian industry over the amendment in the state's agri-marketing act was somewhat muted because of the lack of clarity on the issue of contract farming and the absence of clear guidelines on whether the state government would provide incentives and help in the acquisition of land for private...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

-DNA It's a misconception that high economic growth translates into employment A recent report prepared by the consultancy firm PricewaterhouseCoopers for the Confederation of Indian Industry (CII) harps on the usual premise of boosting economic growth as the basis for job creation. Accordingly, it will still take 20 years to remove unemployment even if India grows at an annual growth rate of 9 per cent. This is exactly what we were...

-The Tribune The outlook for all things smart is opening up, including Climate-Smart Agriculture (CSA). Varanasi, set to develop as a Smart City, will be a lighthouse for sectors seeking sustainable ways to handle demographic pressures, finite environmental resources and climate change. The Finance Minister's budget speech has promised a hundred smart cities. With urban India well covered, it is the turn now of smart agriculture, equipped both to enhance food...

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...